Changes in microRNAs associated with hepatic stellate cell activation status identify signaling pathways. - Wikidata - wikimedia - TriplyDB

Changes in microRNAs associated with hepatic stellate cell activation status identify signaling pathways.

Changes in microRNAs associated with hepatic stellate cell activation status identify signaling pathways.

http://www.wikidata.org/entity/Q43293089

about

A micro RNA processing defect in rapidly progressing idiopathic pulmonary fibrosis miRNA studies in in vitro and in vivo activated hepatic stellate cells Hepatic Stellate Cells and microRNAs in Pathogenesis of Liver Fibrosis MicroRNAs as Important Players in Host-hepatitis B Virus Interactions The role of miRNAs in stress-responsive hepatic stellate cells during liver fibrosis Hepatitis B Virus Infection, MicroRNAs and Liver Disease Therapeutic potential of microRNA: a new target to treat intrahepatic portal hypertension?Emerging role of microRNAs in liver diseases Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges Integrated microRNA and messenger RNA analysis in aortic stenosis.Validation of a serum microRNA panel as biomarkers for early diagnosis of hepatocellular carcinoma post-hepatitis C infection in Egyptian patients MicroRNA function in the profibrogenic interplay upon chronic liver disease.Hepatocyte growth factor (HGF) inhibits collagen I and IV synthesis in hepatic stellate cells by miRNA-29 induction MicroRNAs and the regulation of fibrosis.Class II HDAC inhibition hampers hepatic stellate cell activation by induction of microRNA-29 Gene expression profiling of early hepatic stellate cell activation reveals a role for Igfbp3 in cell migration.Hepatitis C virus infection and hepatic stellate cell activation downregulate miR-29: miR-29 overexpression reduces hepatitis C viral abundance in culture.Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches.Systems Biology Reveals MicroRNA-Mediated Gene Regulation.Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients.Protective role of estrogen-induced miRNA-29 expression in carbon tetrachloride-induced mouse liver injury.miRNA-338-3p/CDK4 signaling pathway suppressed hepatic stellate cell activation and proliferation.Mitochondria-related miR-151a-5p reduces cellular ATP production by targeting CYTB in asthenozoospermia Fuzheng Huayu Recipe Ameliorates Liver Fibrosis by Restoring Balance between Epithelial-to-Mesenchymal Transition and Mesenchymal-to-Epithelial Transition in Hepatic Stellate Cells.Comparison of the differential expression miRNAs in Wistar rats before and 10 days after S.japonicum infection.The mitochondria-targeted antioxidant MitoQ attenuates liver fibrosis in mice.MAPK Signal Transduction Pathway Regulation: A Novel Mechanism of Rat HSC-T6 Cell Apoptosis Induced by FUZHENGHUAYU Tablet Apoptosis and necrosis in the liver MircoRNA-145 promotes activation of hepatic stellate cells via targeting krüppel-like factor 4 MicroRNAs, transforming growth factor beta-1, and tissue fibrosis.Dual role of microRNAs in NAFLD.The rno-miR-34 family is upregulated and targets ACSL1 in dimethylnitrosamine-induced hepatic fibrosis in rats.Dynamic expression of miR-126* and its effects on proliferation and contraction of hepatic stellate cells.Circulating MicroRNAs as potential biomarkers for alcoholic steatohepatitis.Circulating miRNAs as Predictor Markers for Activation of Hepatic Stellate Cells and Progression of HCV-Induced Liver Fibrosis.The mechanisms of HSC activation and epigenetic regulation of HSCs phenotypes Epigenetic regulation of hepatic stellate cell activation and liver fibrosis.Loss of miR-140 is a key risk factor for radiation-induced lung fibrosis through reprogramming fibroblasts and macrophages.A histone deacetylase inhibitor, largazole, decreases liver fibrosis and angiogenesis by inhibiting transforming growth factor-β and vascular endothelial growth factor signalling.Epigenetics and Liver Fibrosis.

P2860

Q21135329-BEF644F9-92A5-4158-8CCD-9C39338AE08F Q24606657-009AA188-06CB-436B-A48B-D65CA8B0F1D9 Q26752932-A36BAF66-209A-4B25-95F3-6E21379DE4E2 Q26781737-9E10E31B-3EA2-4DEF-9355-6E2165AA4E94 Q26797382-8C095CD3-7BB3-4641-B1CA-C67B10A23FAA Q26801511-42392D1D-7FED-48F2-B455-25A42098BE7B Q26829662-45043470-603E-4DC6-BE88-24AD219CBF13 Q27490492-7216ACB9-1C86-47BF-AD25-FF5179662E28 Q28272678-E63CEFEB-048C-446F-A3CD-A7C3B1F8036B Q30829479-4BA92770-A001-49E8-B54E-D7074DA806F7 Q33786041-A7C0EFB6-572C-46A0-8F71-787044888339 Q33907481-073517F4-6BD8-460C-A89A-C9D40D864574 Q34023700-3A6B7A73-0095-456F-86F9-2675B919F186 Q34238322-5CB9D7CB-CDC0-4217-8593-80E9DCAA0A47 Q34576966-C8AD50FA-0EA3-4D9F-B11D-1C8B79A73658 Q35073234-65EBF37F-EA16-4249-84CD-0ACE31ECE42A Q35127629-1DB2398D-DCBC-4E26-B573-9B8FAAE75228 Q35209239-35F288C3-5BB1-4230-B9A5-B223F33238A5 Q35711165-645B3ECD-A7A0-43A6-9FC9-03F0D91ACB00 Q35768016-2B65A5A4-203A-4CF6-A4A4-25FB35B22356 Q35922580-EFD02BC0-F37C-48D6-8CCF-F8D24FA1B2E9 Q36251701-E1612D99-91E9-434F-8F09-B6C6778EB4CD Q36340135-9FC9002D-B560-45CD-8DFE-382C3D441C9D Q36529095-8692EA54-CD76-45B3-97E0-A74CCC5BB24D Q36808603-9063C8AA-161C-42C5-8E25-D48E0C87BC3E Q36879459-B9A18F50-81DA-49BA-8765-2248F66D8395 Q36896262-F93FB96F-9CBE-4858-8DAF-6FB3DF6CE4A0 Q37403072-67141D8C-67DD-4551-8295-7800854349D1 Q37587636-CE0E5B34-A7A8-4223-B169-36884DD9FFF4 Q38050081-47B180FE-32F0-42B6-81A7-3F3355E4DF78 Q38099737-0AC4E736-192D-42CC-954E-0BCB7AE13152 Q38336979-5391A9D5-0F26-4BC7-B3FA-9802FD0185EC Q38484362-9D705787-472C-4192-9A44-638CD40B95A3 Q38490114-3A5DAA6F-8192-49AD-A9CE-46B7A4848461 Q38650644-5C4FB3B1-23F7-4F18-B475-2D4AF65A0E1E Q38896147-3B7DD889-091A-4610-8308-7141F029A875 Q38985933-4F1D2C4C-90B7-4617-BD1C-620DC433F150 Q39084502-6599CCD5-89CD-4C8D-9F4A-56B158E392AB Q39218226-9413300C-EEA1-4990-8F1F-23A3B8456208 Q39358760-756B4BF9-A6C8-42DF-A07B-EF86FEC856F2

P2860

Changes in microRNAs associated with hepatic stellate cell activation status identify signaling pathways.

http://www.wikidata.org/entity/Q43293089

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Changes in microRNAs associate ...... s identify signaling pathways.

@en

Changes in microRNAs associate ...... s identify signaling pathways.

@nl

type

label

Changes in microRNAs associate ...... s identify signaling pathways.

@en

Changes in microRNAs associate ...... s identify signaling pathways.

@nl

prefLabel

Changes in microRNAs associate ...... s identify signaling pathways.

@en

Changes in microRNAs associate ...... s identify signaling pathways.

@nl

P1433

Q43293089-AFC004CD-687C-457C-9F6A-9683AC966190

P1476

Q43293089-8AA5CB42-3AE0-415E-A7E5-BA66B67B3E6C

P2093

Q43293089-20C06A10-1A82-4644-9A13-E86C4FA744FD

Q43293089-32508940-2DC2-4BBB-9851-9805D91029B2

Q43293089-3CFEF546-769A-48F0-8BAF-D5BCC0A47FE5

Q43293089-5A9B568B-13BC-41EA-91E2-895849C12A25

Q43293089-9D69E909-3786-477C-A2E4-7EE5F08C25BC

Q43293089-DDC38F77-464D-44E7-B2A5-5A45CDD8119D

P2860

Q43293089-05AE87C6-32BB-434D-9697-FEB00FF92BBC

Q43293089-066A8B47-7B57-459A-A5DB-ADAFF633C8BE

Q43293089-146629BE-9685-4BFF-98BD-7F6219098CBF

Q43293089-1AF6E6EC-E047-4416-A0CA-394CEB38845F

Q43293089-2B4A835B-0A3E-4DB4-9096-2F6D3132DE6C

Q43293089-30AA1C95-98AD-41FA-8C5A-E94969D68367

Q43293089-42B99D27-A175-48F9-8810-59AE34D6A69E

Q43293089-43586EC9-DFDD-43C8-B22E-86BD9005292D

Q43293089-554E52D8-E45D-4E45-9C6A-222D36608EC3

Q43293089-59034E5A-3C29-4088-BABD-B4483B1F52E0

P304

Q43293089-37D76646-BD49-40A2-8059-6F9841FED930

P31

Q43293089-C1F98F74-8D80-478A-9870-53F2DBB842DF

P356

Q43293089-FBD6BD31-E6EE-42B9-962A-EE2E12D31095

P407

Q43293089-812E3ECF-207D-46E3-BF44-200BE7287890

P433

Q43293089-D45AF5A5-7C35-4568-B2BE-88A54827BAF3

P478

Q43293089-561A4AF1-08EC-4DE3-8E53-18A2581CC085

P577

Q43293089-0C710E97-B154-4A90-8290-A350B2118EC7

P5875

Q43293089-86F87D9E-B3D5-44C6-B18B-B9AEBA17D64D

P698

Q43293089-17970F1E-31ED-45B4-87B6-4C811F275770

P921

Q43293089-AE289440-C7C7-4975-BF35-CCC4E00524E3

P356

J.1742-4658.2009.07213.X

P1433

P1476

Changes in microRNAs associate ...... s identify signaling pathways.

@en

P2093

Bo Jiang

http://www.w3.org/2001/XMLSchema#string

Can-Jie Guo

http://www.w3.org/2001/XMLSchema#string

Ding-Guo Li

http://www.w3.org/2001/XMLSchema#string

Guang-Yu Chen

http://www.w3.org/2001/XMLSchema#string

Qin Pan

http://www.w3.org/2001/XMLSchema#string

Tao Cheng

http://www.w3.org/2001/XMLSchema#string

P2860

Synaptophysin: A novel marker for human and rat hepatic stellate cells

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

The functions of animal microRNAs

The KEGG resource for deciphering the genome

miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: An essential role for apoptosis

Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets

Hypoxic stimulation of vascular endothelial growth factor expression in activated rat hepatic stellate cells

Hepatocyte-specific Smad7 expression attenuates TGF-beta-mediated fibrogenesis and protects against liver damage

Wnt antagonism inhibits hepatic stellate cell activation and liver fibrosis

Adenoviral delivery of dominant-negative transforming growth factor beta type II receptor up-regulates transcriptional repressor SKI-like oncogene, decreases matrix metalloproteinase 2 in hepatic stellate cell and prevents liver fibrosis in rats

P304

5163-5176

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1742-4658.2009.07213.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

276

http://www.w3.org/2001/XMLSchema#string

P577

2009-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26735566

http://www.w3.org/2001/XMLSchema#string

P698

19674103

http://www.w3.org/2001/XMLSchema#string

P921